18F-Fluorodeoxyglucose PET Imaging of Coronary Atherosclerosis and Plaque Inflammation
- 163 Downloads
The emphasis of current cardiovascular imaging modalities is on the anatomic detection of coronary artery luminal narrowing. However, in the clinical setting, vulnerable plaques that are not flow limiting may account for the majority of cardiovascular events. Thus, the pursuit for developing noninvasive imaging techniques that target vulnerable plaques is a laudable goal. Recent studies have demonstrated the clinical feasibility of direct visualization and characterization of coronary and carotid artery plaques with 18F-fluorodeoxyglucose (FDG) positron emission tomography imaging. In experimental studies, the intensity of FDG uptake has been shown to correlate with macrophage density and inflammatory state of plaques. Vascular plaque FDG uptake has been linked to cardiovascular events such as myocardial infarction and stroke. Anti-inflammatory drugs and statins have been shown to attenuate FDG uptake in plaques. Thus, the identification of FDG uptake in vascular plaques may have important clinical implications for predicting and preventing future cardiovascular events.
Keywords18F-Fluorodeoxyglucose PET Atherosclerosis
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: •Of importance
- 9.Dilsizian V, Narula J: Putting the face to a name: concurrent assessment of vascular morphology and biology. J Am Coll Cardiol Imaging 2009, 2:1243–1244.Google Scholar
- 18.Davies JR, Izquierdo-Garcia D, Rudd JH, et al.: FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. Int J Cardiovasc Imaging 2009 Sep 22 (Epub ahead of print).Google Scholar
- 27.• Paulmier B, Duet M, Khayat R, et al.: Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 2008, 15:209–217. This retrospective study showed that vascular FDG uptake can be linked to cardiovascular events in humans.CrossRefPubMedGoogle Scholar
- 28.• Alexanderson E, Slomka P, Cheng V, et al.: Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque. J Nucl Cardiol 2008, 15:841–843. This is an excellent case report showing coronary artery plaque FDG uptake.PubMedGoogle Scholar
- 29.• Wykrzykowska J, Lehman S, Williams G, et al.: Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT inpatients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009, 50:563–568. This paper shows evidence that myocardial background uptake can be suppressed by a high-fat, low-carbohydrate diet.CrossRefPubMedGoogle Scholar